This report provides detailed historical analysis of global market for Minimally Invasive Biopsy Technologies from 2014-2019, and provides extensive market forecasts from 2020-2027 by region/country and subsectors.
Vancouver, BC -- (SBWIRE) -- 01/19/2021 -- The widespread proliferation of minimally invasive surgical technologies and the need for biopsy tests to diagnose cancer cells, identify infections, autoimmune disorders and cases of inflammation have increased the demand for biopsy technologies that are minimally invasive. The constant driving factors for the market for minimally invasive biopsy technologies have been early detection of cancers and higher precision compared to incisional and excisional biopsies.
You Can Download Free Sample PDF Copy of Minimally Invasive Biopsy Technologies Market at https://www.emergenresearch.com/request-sample-form/75
Minimally Invasive Biopsy Technologies Market Drivers
The market size of minimally invasive biopsy technologies was valued at USD 1.08 billion in 2019 and is expected to reach USD 3.98 billion at a CAGR of 17.6% by the year 2027. As the demand for the implementation of minimally invasive surgical procedures in biopsy examinations for many therapeutic applications is increasing extensively worldwide, the global market for minimally invasive biopsy (MIB) technologies is deliberately being promoted. About 66% of North America's total initial breast biopsies are minimally invasive breast biopsies (MIBB). The minimally invasive biopsy technology in patients with imaging-detected suspicious or indeterminate breast lesions has replaced significant numbers of the overall open excisional biopsy.
Minimally Invasive Biopsy Technologies Market: Regional Outlook
Due to its massive implementation in various end-use verticals, particularly in the North American region, the market is projected to see substantial growth. The widespread proliferation of outpatient surgery centers, particularly in the United States, and increasing investment in the healthcare sector are expected to stimulate market demand.
Because of its enormous increase in breast & lung cancers and growing use of MIB technologies, the Asia Pacific region is expected to accelerate with the highest growth rate of 20.1% in the forecast duration from 2020 to 2027.
#Minimally Invasive Biopsy Technologies Market Report to grow your business needs: Now Purchase @ https://www.emergenresearch.com/select-license/75
Key players in the market include Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, and Owlstone Medical Ltd., among others.
Technology Outlook (Revenue: USD Billion; 2017-2027)
Liquid Biopsy
Optical Biopsy
Brush Biopsy
Pigmented Lesion Assays
Breath Biopsy
Brush Biopsy
Others
Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Blood Cancer
Non-oncology Applications
End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
Hospitals & Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
Others
Regional Scope- North America; Europe; Asia Pacific; Central & South America; MEA
Browse complete report description and visit our website @ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market
Table of content:
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Minimally Invasive Biopsy Technologies Market Segmentation & Impact Analysis
4.1. Minimally Invasive Biopsy Technologies Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing proliferation of the minimally invasive surgical procedure
4.2.2.2. Extensive rise in the cancers & biopsy testing
4.2.2.3. Minimum hospitalization for biopsy testing
4.2.3. Market restraints analysis
4.2.3.1. Unavailability of the skilled professional
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Minimally Invasive Biopsy Technologies Market By Technology Insights & Trends, Revenue (USD Billion)
5.1. Technology Dynamics & Market Share, 2019 & 2027
5.1.1. Liquid Biopsy
5.1.2. Optical Biopsy
5.1.3. Brush Biopsy
5.1.4. Pigmented Lesion Assays
5.1.5. Breath Biopsy
5.1.6. Brush Biopsy
5.1.7. Others
Continue…
Related Reports:
Signal Intelligence (SIGINT) Market to Reach USD 18.28 Billion By 2027 | Emergen Research
Sodium Dichromate Market To Be Worth USD 1,242.4 Million by 2027| Emergen Research
Industrial Microbiology Market To Be Worth USD 17.71 Billion by 2027| Emergen Research
Surgical Instrument Tracking Systems Market To Reach USD 431.6 Million by 2027| Emergen Research
Medical Lighting Technologies Market Size To Be Worth USD 2.99 Billion by 2027 | Emergen Research